Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of corifollitropin alfa versus daily recombinant FSH in ovarian stimulation of low responders
2013-002979-17Phase 4Terminated
- Sponsor
- IVI Sevilla
- Start
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of corifollitropin alfa in poor ovarian response (POR) (2 arms), sponsored by IVI Sevilla. Primary endpoint: Number of mature oocytes obtained after follicular puncture. Started Nov 2013; status: terminated.
02
Drugs
corifollitropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on 2013-002979-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002979-17.